Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy

BACKGROUND: The overall treatment time of stereotactic body radiotherapy (SBRT) for non-small-cell lung cancer is usually 3 to over 10 days. If it is longer than 7 days, tumor volume expansion during SBRT may jeopardize the target dose coverage. In this study, volume change of stage I NSCLC during S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatekawa, Kotoha, Iwata, Hiromitsu, Kawaguchi, Takatsune, Ishikura, Satoshi, Baba, Fumiya, Otsuka, Shinya, Miyakawa, Akifumi, Iwana, Maho, Shibamoto, Yuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904205/
https://www.ncbi.nlm.nih.gov/pubmed/24393430
http://dx.doi.org/10.1186/1748-717X-9-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904205/
https://www.ncbi.nlm.nih.gov/pubmed/24393430
http://dx.doi.org/10.1186/1748-717X-9-8

Ejemplares similares